Services provided by the South West Genomic Laboratory Hub
The SWGLH is the point-of-access for all genomic tests listed in the National Genomic Test Directory for rare diseases and for cancer
Funding of tests
The SWGLH is directly funded for service delivery so there will be no provider-to-provider invoicing for tests specified by the national Genomic Test Directory (NGTD), and patients meeting the eligibility criteria.
The following tests will be performed in one of the SWGLH laboratories:
- All cancer and haemato-oncology indications - Bristol
- All common rare disease indications - Bristol or Exeter
- Specialist tests for neurology, cardiac and renal indications - Bristol
- Specialist tests for endocrine indications - Exeter
- National rapid exome sequencing service (R14) - Exeter
Samples for the following test indications should be sent to the SWGLH but will be processed and forwarded to a different specialist laboratory in the GLH network. Results will be sent directly to the requesting clinical team:
- Specialist haematology
- Specialist ophthalmology
- Specialist gastrohepatology
- Specialist hearing
- Specialist immunology
- Specialist inherited cancer
- Specialist metabolic
- Specialist mitochondrial
- Specialist musculoskeletal
- Specialist respiratory
- Specialist skin
- Non-invasive pre-natal diagnosis
The information on requesting these tests can be found on the SWGLH Sample and Test Information pages
Opportunity to update to the National Genomic Test Directory
Calling all clinical teams using the National Genomic Test Directory (NGTD)
This is your annual opportunity to update the NGTD - It will only happen once a year!
The forms can be accessed from these links:
- The form expressing interest for addition of a new clinical indication https://www.england.nhs.uk/wp-content/uploads/2020/12/Test-Evaluation-Application-New-Clinical-Indication-v2.xlsx
- The form expressing interest for addition of amendment to existing clinical indication https://www.england.nhs.uk/wp-content/uploads/2020/12/Test-Evaluation-Application-Amendment-to-Existing-Clinical-Indication-v2.xlsx
If you would like the full guidance document https://www.england.nhs.uk/wp-content/uploads/2020/12/Guidance-Updating-the-National-Genomic-Test-Directory-v1.pdf
NHS England and NHS Improvement will accept applications to update the Test Directory for 2021/22 until 11.59pm on 31st January 2021. Please contact the SWGLH core team if you require assistance in competing the forms.
The 2021/22 update to the Test Directory will be published in April 2021.